Valerie Askanas

18.7k total citations · 1 hit paper
171 papers, 6.7k citations indexed

About

Valerie Askanas is a scholar working on Molecular Biology, Epidemiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Valerie Askanas has authored 171 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Molecular Biology, 71 papers in Epidemiology and 53 papers in Cellular and Molecular Neuroscience. Recurrent topics in Valerie Askanas's work include Inflammatory Myopathies and Dermatomyositis (68 papers), Muscle Physiology and Disorders (62 papers) and Genetic Neurodegenerative Diseases (38 papers). Valerie Askanas is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (68 papers), Muscle Physiology and Disorders (62 papers) and Genetic Neurodegenerative Diseases (38 papers). Valerie Askanas collaborates with scholars based in United States, France and Italy. Valerie Askanas's co-authors include W. King Engel, W. King Engel, Renate B. Alvarez, Anna Nogalska, Janis McFerrin, Takayoshi Kobayashi, Robert C. Griggs, George Karpati, Jerry R. Mendell and Andrew Engel and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Valerie Askanas

171 papers receiving 6.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inclusion body myositis and myopathies

1995 604 citations Valerie Askanas et al. Annals of Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Valerie Askanas United States	47	4.0k	3.2k	1.8k	1.2k	1.1k	171	6.7k
W. King Engel United States	49	3.7k 0.9×	2.5k 0.8×	1.6k 0.9×	1.2k 1.0×	1.1k 1.0×	144	6.9k
B. Eymard France	53	4.4k 1.1×	1.0k 0.3×	2.3k 1.3×	776 0.7×	849 0.8×	240	8.2k
Thomas E. Lloyd United States	37	2.4k 0.6×	1.6k 0.5×	1.0k 0.6×	420 0.4×	1.3k 1.2×	92	4.9k
Zarife Sahenk United States	49	4.6k 1.2×	492 0.2×	1.9k 1.0×	1.4k 1.2×	784 0.7×	145	7.7k
Carlo Minetti Italy	50	5.4k 1.4×	552 0.2×	805 0.5×	1.0k 0.9×	2.4k 2.3×	190	7.5k
Maurizio Moggio Italy	44	4.4k 1.1×	402 0.1×	1.0k 0.6×	883 0.8×	415 0.4×	195	6.2k
Manuel Yepes United States	41	2.4k 0.6×	1.5k 0.5×	853 0.5×	647 0.6×	763 0.7×	95	5.9k
Robert H. Baloh United States	49	5.0k 1.3×	874 0.3×	3.0k 1.7×	1.3k 1.1×	1.0k 1.0×	88	9.7k
Claudia Sandri Italy	13	3.9k 1.0×	1.2k 0.4×	488 0.3×	1.8k 1.5×	1.0k 1.0×	17	4.9k
Yun Chen United States	34	3.7k 0.9×	1.2k 0.4×	553 0.3×	939 0.8×	345 0.3×	84	5.9k

Countries citing papers authored by Valerie Askanas

Since Specialization

Citations

This map shows the geographic impact of Valerie Askanas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valerie Askanas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valerie Askanas more than expected).

Fields of papers citing papers by Valerie Askanas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valerie Askanas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valerie Askanas. The network helps show where Valerie Askanas may publish in the future.

Co-authorship network of co-authors of Valerie Askanas

This figure shows the co-authorship network connecting the top 25 collaborators of Valerie Askanas. A scholar is included among the top collaborators of Valerie Askanas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valerie Askanas. Valerie Askanas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Askanas, Valerie, W. King Engel, & Anna Nogalska. (2014). Sporadic inclusion-body myositis: A degenerative muscle disease associated with aging, impaired muscle protein homeostasis and abnormal mitophagy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(4). 633–643. 78 indexed citations

Nogalska, Anna, et al.. (2014). Abnormalities of Mitophagy in Sporadic Inclusion-Body Myositis (s-IBM) Muscle Fibers (P3.288). Neurology. 82(10_supplement). 3 indexed citations

Nogalska, Anna, Carla D’Agostino, W. King Engel, & Valerie Askanas. (2014). Sodium phenylbutyrate reverses lysosomal dysfunction and decreases amyloid-β42 in an in vitro-model of inclusion-body myositis. Neurobiology of Disease. 65. 93–101. 10 indexed citations

Nogalska, Anna, Carla D’Agostino, W. King Engel, William L. Klein, & Valerie Askanas. (2010). Novel demonstration of amyloid-β oligomers in sporadic inclusion-body myositis muscle fibers. Acta Neuropathologica. 120(5). 661–666. 38 indexed citations

Nogalska, Anna, Carla D’Agostino, Chiara Terracciano, W. King Engel, & Valerie Askanas. (2010). Impaired Autophagy in Sporadic Inclusion-Body Myositis and in Endoplasmic Reticulum Stress-Provoked Cultured Human Muscle Fibers. American Journal Of Pathology. 177(3). 1377–1387. 84 indexed citations

Nogalska, Anna, Chiara Terracciano, Carla D’Agostino, W. King Engel, & Valerie Askanas. (2009). p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis. Acta Neuropathologica. 118(3). 407–413. 116 indexed citations

Wójcik, Sławomir, Anna Nogalska, W. King Engel, & Valerie Askanas. (2007). G.P.3.16 In skeletal muscle of patients with type-II fiber atrophy, myostatin (MSTN) and myostatin precursor protein (MSTN-PP) are both increased. Neuromuscular Disorders. 17(9-10). 787–787. 1 indexed citations

Terracciano, Chiara, Anna Nogalska, W. King Engel, Sławomir Wójcik, & Valerie Askanas. (2007). G.O.2 In sporadic inclusion-body myositis (s-IBM) muscle fibers, Parkinson-disease-associated DJ-1 is oxidized and might play a novel pathogenic role. Neuromuscular Disorders. 17(9-10). 766–767. 1 indexed citations

Yang, Chih‐Chao, Renate B. Alvarez, W. King Engel, & Valerie Askanas. (1996). Increase of nitric oxide synthases and nitrotyrosine in inclusion-body myositis. Neuroreport. 8(1). 153–158. 65 indexed citations

10.

Bilak, Masako M., Valerie Askanas, & W. King Engel. (1993). Strong immunoreactivity of ?1 co-localizes with ?-amyloid protein and ubiquitin in vacuolated muscle fibers of inclusion-body myositis. Acta Neuropathologica. 85(4). 378–382. 42 indexed citations

11.

Askanas, Valerie, et al.. (1993). β-amyloid precursor protein mRNA is increased in inclusion-body myositis muscle. Neuroreport. 4(6). 815–818. 79 indexed citations

12.

Askanas, Valerie, W. King Engel, & Renate B. Alvarez. (1992). Light and electron microscopic localization of beta-amyloid protein in muscle biopsies of patients with inclusion-body myositis.. PubMed. 141(1). 31–6. 118 indexed citations

13.

Kobayashi, Takayoshi, Valerie Askanas, & W. King Engel. (1990). <b>HIGH EXCITABILITY AND REMAINED SLOW CALCIUM REPOLARIZATION COMPONENTS OF ACTION POTENTIALS IN CULTURED HUMAN PARAMYOTONIA CONGENITA MUSCLE </b><b>CELLS </b>. Biomedical Research. 11(5). 299–305. 1 indexed citations

14.

Martinuzzi, Andrea, Valerie Askanas, & W. King Engel. (1990). Paralysis of Innervated Cultured Human Muscle Fibers Affects Enzymes Differentially. Journal of Neurochemistry. 54(1). 223–229. 8 indexed citations

15.

Martinuzzi, Andrea, Valerie Askanas, Takayoshi Kobayashi, W. King Engel, & S. Di Mauro. (1986). Expression of muscle-gene-specific isozymes of phosphorylase and creatine kinase in innervated cultured human muscle.. The Journal of Cell Biology. 103(4). 1423–1429. 54 indexed citations

16.

Askanas, Valerie, W. King Engel, & Takayoshi Kobayashi. (1985). Thyrotropin‐releasing hormone enhances motor neuron–evoked contractions of cultured human muscle. Annals of Neurology. 18(6). 716–719. 42 indexed citations

17.

Avigan, Joel, Valerie Askanas, & W. King Engel. (1983). Muscle carnitine deficiency. Neurology. 33(8). 1021–1021. 17 indexed citations

18.

Askanas, Valerie, et al.. (1980). Cultured muscle fibers of gyrate atrophy (GA) patients: Tubules, ornithine toxicity, and 1-ornithine-2-oxoacid aminotransferase (OAT) deficiency. 30(4). 1 indexed citations

19.

Askanas, Valerie & Werner Engel. (1975). Distinct histochemical subtypes of type I fibers of human skeletal muscle.. PubMed. 100. 161–3. 3 indexed citations

20.

Askanas, Valerie, et al.. (1971). Sandwich Embedding of Multiple Layers of Muscle Tissue Culture for Serial Frozen Sectioning. Stain Technology. 46(6). 322–324. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact